跳至主要内容
临床试验/CTRI/2025/04/085465
CTRI/2025/04/085465尚未招募3 期

Evaluation of Safety and visual Performance of Cast molded, Preloaded Hydrophobic Intraocular lenses (IOL) in age-related Cataract patients

Aurolab1 个研究点 分布在 1 个国家目标入组 105 人开始时间: 2025年10月5日最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方
Aurolab
入组人数
105
试验地点
1
主要终点
-Best Uncorrected Distance Visual Acuity

研究概览

简要总结

-The main aim of this study is to determine the safety and efficacy of Aurolabs Cast molded Preloaded Hydrophobic Intraocular lenses (IOL) in age related cataract patients

-Primary Objective will be Best uncorrected distance visual acuity and  Secondary Objective will be Incidence of PCO formation and Glistening of IOL

-105 patients meeting the inclusion criteria will be enrolled in this study and written consent will be taken from all the patients

-Preoperative examination will include refraction, keratometry slitlamp biomicroscopy noncontact tonometry and detailed fundus examination

  • Surgical procedure will be the same for all phacoemulsification with Cast molded IOL implantation

-Surgeon will record any intra operative complications

-Patients will be followed up on  1 day 1week 1 month 6 months and 1 year

-Postoperative examination will include Visual acuity Refraction non- contact tonometry Anterior segment and fundus evaluation by slit lamp examination

-Glistening and PCO assessment will be performed by slit lamp bio microscopy using high powered magnification and the same will be evaluated by MIYATA SCALE and EPCO  respectively

-Subjects will be evaluated for occurrence of post-operative complications like Iritis Corneal edema Uveitis Rise in IOP Postop Endophthalmitis Postop CME PCO formation during each follow up

-The performance endpoints will be UCDVA BCDVA IOL stability and patients satisfaction

The safety endpoints will be occurrence and frequency of adverse events

研究设计

研究类型
Interventional
分配方式
Not Applicable
盲法
Not Applicable

入排标准

年龄范围
40.00 Year(s) 至 80.00 Year(s)(—)
性别
All

入选标准

  • 1 Senile cataract eligible for phaco emulsification cataract surgery 2 Clear intraocular media other than cataract 3 Age above 40 years 4 BCVA equal to less than 6/12 in the study eye 5 Pre operative corneal astigmatism less than one diopter 6 Able to read understand and provide informed consent.

排除标准

  • 1 Uncontrolled Diabetic retinopathy or systemic hypertension or cardiac disorder 2 Pseudo exfoliation 3 Traumatic cataract 4 Small pupil 5 Any pre existing corneal pathologies or dry eyes 6 Post lasik or refractive surgeries 7 Uncontrolled glaucoma or on treatment for glaucoma in either eye 8 Preoperative retinal detachment or clinically significant retinal pathology in the operative eye 9 Congenital cataracts 10 Prior ocular surgery in the study eye.

结局指标

主要结局

-Best Uncorrected Distance Visual Acuity

时间窗: - 1 day | - 1 week | - 1 month | - 6 months | - 1 year

次要结局

  • -Incidence of PCO formation(-Glistening of IOL)

研究者

发起方
Aurolab
申办方类型
Other [Ophthalmic and Pharmaceutical manufacturing industry]

研究点 (1)

Loading locations...

相似试验